EISAI MANUFACTURING LIMITED

Mosquito Way, Hatfield, United Kingdom

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (2)

A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive gastroesophageal Reflux Disease (GERD) - Not applicable

Active, not recruiting

Jun 20081,060 participants

A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive gastroesophageal Reflux Disease (GERD) - Not applicable

Active, not recruiting

Jun 20081,060 participants

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

SFDA

Saudi Food and Drug Authority

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

Dayvigo 5mg Film coated tablet

NPRA

2025-11-28

Fycompa 4mg Film-coated Tablets

NPRA

2025-11-28

Dayvigo 10mg Film coated tablet

NPRA

2025-11-28

Fycompa 2mg Film-coated Tablets

NPRA

2025-11-28

FYCOMPA 2 mg Film-Coated Tablet

FYCOMPA 8 mg Film-Coated Tablet

SFDA

2025-07-18

FYCOMPA 10 mg Film-Coated Tablet

SFDA

2025-07-18

FYCOMPA 6 mg Film-Coated Tablet

SFDA

2025-07-18

News

No news articles found

Back to Organizations